Brain artery treatment for chronic subdural hematoma
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This study tests a new way to treat chronic subdural hematomas (a type of bleeding on the brain) by using a very thin tube to seal off a small artery inside the head. This may help the blood clot shrink without needing a traditional surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 100 years old
- You must have a chronic subdural hematoma on the top or side of your brain
- You must be able to consent to treatment
- If your blood clot causes symptoms, you can join the study
- If your blood clot is large but not causing symptoms, you can join after at least 6 weeks of non-surgical treatment that hasn't worked
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with chronic subdural hematoma (a type of bleeding around the brain) who receive a procedure called middle meningeal artery embolization, which reduces blood flow to prevent rebleeding. Researchers will track your recovery with imaging and clinical assessments to understand how well this treatment works.
This study tests a procedure called middle meningeal artery embolization for people with a confirmed chronic subdural hematoma (a long-lasting bleed near the brain). It may help by reducing the blood supply to the area and improving symptoms after symptoms start or worsen.
This trial tests a new technique during surgery for chronic subdural haematoma (bleeding between the brain and skull) where doctors use heat or special tools to seal a blood vessel (the middle meningeal artery) to help prevent the bleed from returning. The goal is to see if this addition to standard surgery is safe and feasible.
This trial tests a new minimally invasive procedure using PHIL, a liquid embolic agent, to treat chronic subdural hematoma—bleeding on the brain that develops slowly over weeks. Instead of surgery, doctors inject PHIL into the middle meningeal artery to reduce bleeding and relieve symptoms like headaches, dizziness, or weakness.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This trial looks at whether a procedure called middle meningeal artery embolization can help stop chronic subdural hematoma (slow bleeding/collection under the brain covering) from coming back after your first surgery. It studies an added endovascular treatment right after your operation to reduce recurrence.
Hear when a new Chronic Subdural Hematomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.